
Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinoma
Keywords: MDM2; Esophageal neoplasms; Chemoradiotherapy; MLH1; MDM2; p53; pRb; Immunohistochemistry